| Nuclear receptor coactivators and corepressors. KB Horwitz, TA Jackson, DL Bain, JK Richer, GS Takimoto, L Tung Molecular Endocrinology 10 (10), 1167-1177, 1996 | 1289 | 1996 |
| Differential gene regulation by the two progesterone receptor isoforms in human breast cancer cells JK Richer, BM Jacobsen, NG Manning, MG Abel, KB Horwitz, DM Wolf Journal of Biological Chemistry 277 (7), 5209-5218, 2002 | 717 | 2002 |
| The partial agonist activity of antagonist-occupied steroid receptors is controlled by a novel hinge domain-binding coactivator L7/SPA and the corepressors N-CoR or SMRT TA Jackson, JK Richer, DL Bain, GS Takimoto, L Tung, KB Horwitz Molecular endocrinology 11 (6), 693-705, 1997 | 609 | 1997 |
| Progesterone regulates transcription of the p21WAF1 cyclindependent kinase inhibitor gene through Sp1 and CBP/p300 GI Owen, JK Richer, L Tung, G Takimoto, KB Horwitz Journal of Biological Chemistry 273 (17), 10696-10701, 1998 | 443 | 1998 |
| Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamide DR Cochrane, S Bernales, BM Jacobsen, DM Cittelly, EN Howe, ... Breast Cancer Research 16, 1-19, 2014 | 440 | 2014 |
| MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents DR Cochrane, NS Spoelstra, EN Howe, SK Nordeen, JK Richer Molecular cancer therapeutics 8 (5), 1055-1066, 2009 | 401 | 2009 |
| Targets of miR-200c mediate suppression of cell motility and anoikis resistance EN Howe, DR Cochrane, JK Richer Breast cancer research 13, 1-15, 2011 | 293 | 2011 |
| A TDO2-AhR signaling axis facilitates anoikis resistance and metastasis in triple-negative breast cancer NC D'Amato, TJ Rogers, MA Gordon, LI Greene, DR Cochrane, ... Cancer research 75 (21), 4651-4664, 2015 | 259 | 2015 |
| Convergence of progesterone and epidermal growth factor signaling in breast cancer: potentiation of mitogen-activated protein kinase pathways CA Lange, JK Richer, T Shen, KB Horwitz Journal of Biological Chemistry 273 (47), 31308-31316, 1998 | 259 | 1998 |
| Convergence of progesterone with growth factor and cytokine signaling in breast cancer: progesterone receptors regulate signal transducers and activators of transcription … JK Richer, CA Lange, NG Manning, G Owen, R Powell, KB Horwitz Journal of Biological Chemistry 273 (47), 31317-31326, 1998 | 258 | 1998 |
| Multiple Molecular Subtypes of Triple-Negative Breast Cancer Critically Rely on Androgen Receptor and Respond to Enzalutamide In Vivo VN Barton, NC D'Amato, MA Gordon, HT Lind, NS Spoelstra, BL Babbs, ... Molecular cancer therapeutics 14 (3), 769-778, 2015 | 255 | 2015 |
| Hypothesis: progesterone primes breast cancer cells for cross-talk with proliferative or antiproliferative signals CA Lange, JK Richer, KB Horwitz Molecular Endocrinology 13 (6), 829-836, 1999 | 247 | 1999 |
| Loss of miR-200c: a marker of aggressiveness and chemoresistance in female reproductive cancers DR Cochrane, EN Howe, NS Spoelstra, JK Richer Journal of oncology 2010, 2010 | 237 | 2010 |
| Downregulation of miR-342 is associated with tamoxifen resistant breast tumors DM Cittelly, PM Das, NS Spoelstra, SM Edgerton, JK Richer, AD Thor, ... Molecular cancer 9, 1-12, 2010 | 230 | 2010 |
| The transcription factor ZEB1 is aberrantly expressed in aggressive uterine cancers NS Spoelstra, NG Manning, Y Higashi, D Darling, M Singh, KR Shroyer, ... Cancer research 66 (7), 3893-3902, 2006 | 208 | 2006 |
| Progesterone-independent effects of human progesterone receptors (PRs) in estrogen receptor-positive breast cancer: PR isoform-specific gene regulation and tumor biology BM Jacobsen, SA Schittone, JK Richer, KB Horwitz Molecular endocrinology 19 (3), 574-587, 2005 | 202 | 2005 |
| MicroRNAs link estrogen receptor alpha status and Dicer levels in breast cancer DR Cochrane, DM Cittelly, EN Howe, NS Spoelstra, EL McKinsey, ... Hormones and Cancer 1, 306-319, 2010 | 171 | 2010 |
| Selective down-regulation of progesterone receptor isoform B in poorly differentiated human endometrial cancer cells: implications for unopposed estrogen action NS Kumar, J Richer, G Owen, E Litman, KB Horwitz, KK Leslie Cancer research 58 (9), 1860-1865, 1998 | 170 | 1998 |
| ZEB1 expression in type I vs type II endometrial cancers: a marker of aggressive disease M Singh, NS Spoelstra, A Jean, E Howe, KC Torkko, HR Clark, ... Modern Pathology 21 (7), 912-923, 2008 | 163 | 2008 |
| The miR-200 and miR-221/222 microRNA families: opposing effects on epithelial identity EN Howe, DR Cochrane, JK Richer Journal of mammary gland biology and neoplasia 17, 65-77, 2012 | 156 | 2012 |
